Index of medicine substances

Rabbit anti-human lymphocyte immunoglobulin

Indicated for: prevention and treatment of transplant rejection

L04AA04 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants

Rabeprazole

Indicated for: peptic ulcer; gastroesophageal reflux

A02BC04 Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors

Rabies vaccine inactivated

Indicated for: prevention of rabies

J07BG01 Antiinfectives for systemic use | Viral vaccines | Rabies vaccines

Racecadotril

Indicated for: diarrhea

A07XA04 Alimentary tract and metabolism | Other antidiarrheals

RADAMTS13

Indicated for: congenital thrombotic thrombocytopenic purpura; ADAMTS13 deficiency

B01AD13 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Enzymes

Radiopharmaceuticals

Indicated for: diagnostic imaging

V09GA01 Various | Cardiovascular system | Technetium (99mtc) compounds

Radiopharmaceuticals (18F fluorocholine chloride)

Indicated for: diagnostic imaging

V09IX07 Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection

Raloxifene

Indicated for: osteoporosis

G03XC01 Genito urinary system and sex hormones | Other sex hormones and modulators of the genital system | Selective estrogen receptor modulators

Raltegravir

Indicated for: HIV-1 infection

J05AJ01 Antiinfectives for systemic use | Direct acting antivirals | Integrase inhibitors

Ramipril

Indicated for: hypertension

C09AA05 Cardiovascular system | Ace inhibitors, plain

Ramipril + amlodipine

Indicated for: hypertension

C09BB07 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers

Ramipril + hydrochlorothiazide

Indicated for: hypertension

C09BA05 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics

Ramipril + indapamide

Indicated for: hypertension

C09BA05 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics

Ramipril + nebivolol

Indicated for: arterial hypertension

Ramucirumab

Indicated for: cancer

L01FG02 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Vegf/vegfr (vascular endothelial growth factor) inhibitors

Ranibizumab

Indicated for: macular degeneration; diabetic macular edema

S01LA04 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents

Ranitidine

Indicated for: peptic ulcer; gastroesophageal reflux

A02BA02 Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | H2-receptor antagonists

Ranolazine

Indicated for: angina pectoris

C01EB18 Cardiovascular system | Other cardiac preparations

Rasagiline

Indicated for: Parkinson's disease

N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors

Rasburicase

Indicated for: hyperuricemia in tumor lysis syndrome

V03AF07 Various | All other therapeutic products | All other therapeutic products | Detoxifying agents for antineoplastic treatment

Ravulizumab

Indicated for: complement-mediated disorders

L04AA43 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants

Red vine leaf extract

Indicated for: chronic venous insufficiency; lower limb edema

C05CXN2 Cardiovascular system | Capillary stabilizing agents | Other capillary stabilizing agents

Refined dry extract from green tea leaves

Indicated for: herbal symptomatic treatment

D06BB12 Dermatologicals | Chemotherapeutics for topical use | Antivirals

Regadenosone

Indicated for: pharmacologic stress test for myocardial perfusion

C01EB21 Cardiovascular system | Other cardiac preparations

Regdanvimab

Indicated for: COVID-19

J06BD06 Antiinfectives for systemic use | Immunoglobulins | Antiviral monoclonal antibodies

Regorafenib

Indicated for: gastrointestinal stromal tumors

L01EX05 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Relugolix

Indicated for: prostate cancer

L02BX04 Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Other hormone antagonists and related agents

Relugolix + estradiol + norethisterone

Indicated for: menopausal symptoms

H01CC54 Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Anti-gonadotropin-releasing hormones

Remdesivir

Indicated for: COVID-19

J05AB16 Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors

Remibrutinib

Indicated for: chronic spontaneous urticaria

L04AA60 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants